Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 9,851 |
|
|||||
| News | - | ||||||
| Day High | 8.23 | Low High |
|||||
| Day Low | 7.81 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aeterna Zentaris Inc | AEZS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.39 | 4.97% | 8.23 | 23:00:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.81 | 7.81 | 8.23 | 8.23 | 7.84 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 141 | 9,851 | US$ 7.93 | US$ 78,161 | - | 1.3601 - 8.3487 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 2 | US$ 8.02 | USD |
Aeterna Zentaris Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 39.96M | 4.86M | - | 4.5M | -16.55M | -3.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aeterna Zentaris News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEZS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.80 | 8.3487 | 7.74 | 7.87 | 10,792 | 0.43 | 5.51% |
| 1 Month | 2.04 | 8.3487 | 1.95 | 3.17 | 13,625 | 6.19 | 303.43% |
| 3 Months | 1.88 | 8.3487 | 1.68 | 2.31 | 18,443 | 6.35 | 337.77% |
| 6 Months | 1.53 | 8.3487 | 1.45 | 2.17 | 15,945 | 6.70 | 437.91% |
| 1 Year | 3.10 | 8.3487 | 1.3601 | 2.32 | 12,676 | 5.13 | 165.48% |
| 3 Years | 0.9468 | 8.3487 | 0.1645 | 0.658198 | 565,028 | 7.28 | 769.24% |
| 5 Years | 3.13 | 8.3487 | 0.1645 | 1.14 | 1,843,291 | 5.10 | 162.94% |
Aeterna Zentaris Description
| AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. |
